the possible advantages of the monobactam antibiotic aztreonam in the treatment of hospital-acquired urinary tract infection were assessed in a study comparing aztreonam ( 0.5 to 1 g twice daily or three times daily ) to cefamandole ( 1 g three times daily ) in 159 patients .
C0042029
of
C0004521
aztreonam